A recent systematic review of clinical trials of HIV antiretroviral medications showed women were less than a quarter of participants. The authors noted that this could limit the generalisability of findings as women can absorb drugs differently and respond differently to medication (side effects). [Read more…] about Women under-represented in HIV clinical trials
There’s a lot of news coming out of the big international conference on retroviruses and opportunistic infections in the US this week: CROI 2015., which you can follow if you are on Twitter at #CROI2015 or you can go to AIDSmap for news items about the conference.
The highlights so far include results from two trials which indicate the effectiveness of pre-exposure prophylaxis (PrEP) for gay men. Reports from the Partners Demonstration Project also indicate the efficacy of PrEP and antiretroviral treatment as a transitional strategy for serodiscordant heterosexual couples.
Eviplera is a great new pill taken just once a day, with few side effects. However you must eat a good meal with it.
Here are some examples from the NHS (UK) of things you should eat with Eviplera.
HIV treatment update 2014 for Sydney West
Guest speakers: Dr Virginia Furner (HIV treatment update 2014)
Dr Rick Varma will help answer all your questions.
Who is it for? Positive heterosexual men and women, partners & family
Where is it? St Marys Mamre Homestead
When is it? Saturday 21st June 10.30 am until 3pm
Come along and get copies of the new Pozhet booklets, stay up-to-date with advances in knowledge about HIV and connect with other in a safe and supportive environment.
Please RSVP by the 18th June
For details ring Elizabeth on 0400 431 809 or Susan on 1800 812 404
Lunch will be provided
The online edition of the US Journal of Infectious Diseases (on AIDSmap) reports that high concentrations of HIV treatment (ART) were found in the vaginal secretions of women in a study. The findings support the use of ART to prevent sexual transmission of HIV.
The investigators wanted to see if ART had any effect on HIV in vaginal secretions, particularly during menstruation.